1. Home
  2. SRRK vs Z Comparison

SRRK vs Z Comparison

Compare SRRK & Z Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$43.58

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo Zillow Group Inc. Class C Capital Stock

Z

Zillow Group Inc. Class C Capital Stock

SELL

Current Price

$28.04

Market Cap

8.0B

ML Signal

SELL

Company Overview

Basic Information
Metric
SRRK
Z
Founded
2012
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
8.0B
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
SRRK
Z
Price
$43.58
$28.04
Analyst Decision
Strong Buy
Hold
Analyst Count
18
7
Target Price
★ $70.44
$46.00
AVG Volume (30 Days)
2.2M
★ 3.8M
Earning Date
11-13-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 118.75
EPS
N/A
★ 0.18
Revenue
N/A
★ $1,076,794,000.00
Revenue This Year
N/A
$14.15
Revenue Next Year
$1,978.85
$11.72
P/E Ratio
★ N/A
$152.17
Revenue Growth
N/A
★ 27.19
52 Week Low
$27.07
$26.67
52 Week High
$61.76
$79.39

Technical Indicators

Market Signals
Indicator
SRRK
Z
Relative Strength Index (RSI) 30.08 37.23
Support Level $41.51 N/A
Resistance Level $50.09 $37.21
Average True Range (ATR) 2.34 1.17
MACD -0.63 -0.15
Stochastic Oscillator 13.26 22.42

Price Performance

Historical Comparison
SRRK
Z

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About Z Zillow Group Inc. Class C Capital Stock

Zillow Group Inc is a real estate technology company offering a digital platform that connects real estate customers with sellers, agents, loan officers, and other real estate-related professionals. With its tools and resources, Zillow helps real estate professionals grow their businesses, and for renters and housing providers, it offers a marketplace along with a set of end-to-end products and services to streamline applications, leases, payments, and more. The group operates various brands such as Zillow, Zillow Home Loans, Zillow Rentals, Zillow New Construction, Trulia, StreetEasy, Out East, HotPads, Follow Up Boss, ShowingTime, dotloop, and Zillow Closing. Its ecosystem spans the entire home journey from shopping to renting, buying, selling, and financing real estate.

Share on Social Networks: